Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000525648 | SCV000650051 | pathogenic | Rett syndrome, congenital variant | 2017-05-30 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. A different truncation downstream of this variant (p.Gly169Alafs*23) has been determined to be pathogenic (PMID: 25356899, Invitae). This suggests that deletion of this region of the FOXG1 protein is causative of disease. This variant has not been reported in the literature in individuals with a FOXG1-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change results in a premature translational stop signal in the FOXG1 gene (p.Glu167Glyfs*25). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 323 amino acids of the FOXG1 protein. |
Laboratory of Medical Genetics, |
RCV000525648 | SCV002577595 | pathogenic | Rett syndrome, congenital variant | 2022-03-23 | criteria provided, single submitter | clinical testing | PVS1, PM2, PP5 |